Comorbidities
13
4
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network
Tailored Stapled SADI-S: Initial Report and Preliminary Results
Headache Registration and Followup Initiated by Tongji Hospital, HUST
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study
Access to Kidney Transplant of Obese Patients Beginning Dialysis
Vital Signs Monitoring in Rehabilitation Center Patients
Method of Measuring Comorbidity to Predict Outcome After Intensive Care
Advance Care Planning & Goals of Care Randomized Controlled Trial in Primary Care
Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)
Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms